🏢 官网IRRVTYCodex · 实盘不做把握 9/10
北京时间·🕒 发布 20:00:00时区推断·⟳ 抓取 20:01:32回填·⚡ 决策 07-20 20:02:41·99.2 天前
Revvity发布2026影响力报告并首次披露部分Scope 3排放
这是公司年度ESG/可持续发展影响力报告，内容集中在排放披露、员工留任、废弃物分流和小额科研资助，不改变短期收入、利润、订单或监管边界。
📄 原文RVTY↗ 原文
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
Revvity, Inc. - Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure Sk…
不做 Revvity（RVTY.US）
年度ESG/影响力报告属于品牌与治理披露，180,000美元科研资助相对公司29亿美元收入极小，且Scope 3披露、减排和员工留任指标不构成短线收入或利润催化，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-20 · 扩散 low · price-in 风险 low ↗
关键理由
- 这是公司年度ESG/可持续发展影响力报告，内容集中在排放披露、员工留任、废弃物分流和小额科研资助，不改变短期收入、利润、订单或监管边界。
主要风险
- 若后续另有客户订单、监管处罚或资本开支变化，需要作为新事件重新评估。
原文全文
展开原文 · 4,720 字
Revvity, Inc. - Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
Skip to main content
Investor Home
News
Investor News
Newsroom
Acquisitions
Events
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Dividend History
Analyst Coverage
Search query
News Details
View All News
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
July 20, 2026
Download
(opens in new window)
WALTHAM, Mass.--(BUSINESS WIRE)--
Revvity, Inc.
(NYSE: RVTY) today published its 2026
Impact Report
, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company continues to translate innovation into real-world impact, while embedding responsible and sustainable practices through its operations.
"At Revvity, we believe scientific innovation and responsible business practices go hand in hand," said Prahlad Singh, president and chief executive officer at Revvity. "We are proud of the progress we've made advancing our environmental, social and governance priorities, from strengthening transparency and environmental stewardship to expanding access to healthcare and investing in our people and communities."
The 2026 Impact Report highlights the Company’s key achievements, including:
Disclosing material Scope 3 emissions for the first time, which marks an expansion of the Company’s sustainability reporting.
Reducing carbon footprint by lowering Scope 1 and 2 greenhouse gas emissions by 1.3% in 2025 (16% total reduction from the 2022 baseline).
Achieving a 49% non-hazardous diversion rate, surpassing the Company’s annual goal of 40%.
Advanced talent retention and workforce development initiatives, reducing voluntary turnover to 7% from 9% and filling 24% of open roles through internal promotions and transfers.
Launching the Revvity Supports Research (RSR) initiative, which provides general research grants totaling $180,000 to 12 key academic institutions whose work aligns with the scientific areas the Company supports.
To learn more about Revvity’s commitments and progress, visit
esg.revvity.com
.
About Revvity
At Revvity, "impossible" is inspiration, and "can't be done" is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.
Stay updated by following our
,
LinkedIn
X
YouTube
Facebook
and
Instagram
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Source: Revvity
Stay in the Loop
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At Revvity, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Revvity, Inc. to send you the requested Investor Email Alert updates.
* Required
Email Address
*
Investor Alert Options
Quarterly Reports
Events & Presentations
Unsubscribe
Email Alert Sign Up Confirmation
Investor Contact
ir@revvity.com
@revvityIR
Transfer Agent
(For Individual Shareholder FAQ's)
www.computershare.com/investor
www-us.computershare.com/QuickAccessHub
US 877 373 6374
International +1 (201) 680 6578
Purpose
Approach
Our Story
Leadership
FAQ’s
Press
Announcements
Press Coverage
Awards
Environmental
Social
Governance
Investors
Career
Career Home
Why Revvity
Search Jobs
Privacy Policy
Cookies Policy
Terms of Use
Accessibility
©Revvity Inc. - All rights reserved
Powered By Q4 Inc.
5.183.0.4
Skip to main content
Investor Home
News
Investor News
Newsroom
Acquisitions
Events
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Dividend History
Analyst Coverage
Search query
News Details
View All News
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
July 20, 2026
Download
(opens in new window)
WALTHAM, Mass.--(BUSINESS WIRE)--
Revvity, Inc.
(NYSE: RVTY) today published its 2026
Impact Report
, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company continues to translate innovation into real-world impact, while embedding responsible and sustainable practices through its operations.
"At Revvity, we believe scientific innovation and responsible business practices go hand in hand," said Prahlad Singh, president and chief executive officer at Revvity. "We are proud of the progress we've made advancing our environmental, social and governance priorities, from strengthening transparency and environmental stewardship to expanding access to healthcare and investing in our people and communities."
The 2026 Impact Report highlights the Company’s key achievements, including:
Disclosing material Scope 3 emissions for the first time, which marks an expansion of the Company’s sustainability reporting.
Reducing carbon footprint by lowering Scope 1 and 2 greenhouse gas emissions by 1.3% in 2025 (16% total reduction from the 2022 baseline).
Achieving a 49% non-hazardous diversion rate, surpassing the Company’s annual goal of 40%.
Advanced talent retention and workforce development initiatives, reducing voluntary turnover to 7% from 9% and filling 24% of open roles through internal promotions and transfers.
Launching the Revvity Supports Research (RSR) initiative, which provides general research grants totaling $180,000 to 12 key academic institutions whose work aligns with the scientific areas the Company supports.
To learn more about Revvity’s commitments and progress, visit
esg.revvity.com
.
About Revvity
At Revvity, "impossible" is inspiration, and "can't be done" is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.
Stay updated by following our
,
X
YouTube
and
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Source: Revvity
Stay in the Loop
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At Revvity, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Revvity, Inc. to send you the requested Investor Email Alert updates.
* Required
Email Address
*
Investor Alert Options
Quarterly Reports
Events & Presentations
Unsubscribe
Email Alert Sign Up Confirmation
Investor Contact
ir@revvity.com
@revvityIR
Transfer Agent
(For Individual Shareholder FAQ's)
www.computershare.com/investor
www-us.computershare.com/QuickAccessHub
US 877 373 6374
International +1 (201) 680 6578
Purpose
Approach
Our Story
Leadership
FAQ’s
Press
Announcements
Press Coverage
Awards
Environmental
Social
Governance
Investors
Career
Career Home
Why Revvity
Search Jobs
Privacy Policy
Cookies Policy
Terms of Use
Accessibility
©Revvity Inc. - All rights reserved
Powered By Q4 Inc.
5.183.0.4
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。